[{"address1": "1-8, Doshomachi 3-chome", "address2": "Chuo-ku", "city": "Osaka", "zip": "541-0045", "country": "Japan", "phone": "81 6 6202 2161", "fax": "81 6 6229 9596", "website": "https://www.shionogi.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug. It also develops S-872600 an influenza nasal vaccine; S-875670 anCOVID-19 nasal vaccine; S-540956 a nucleic acid adjuvant; S-554110 a nontuberculous mycobacterial infection; S-337395 for RSV infections; S-892216 for COVID-19 therapeutics; Olorofim for invasive aspergillosis; cefiderocol for aerobic gram-negative bacterial infections and infectious diseases; S-268019 a COVID-19 prophylactic vaccine; S-268019 a prophylactic vaccine for COVID-19; ensitrelvir for COVID-19 treatment and prevention; baloxavir for influenza virus infection; S-365598 for HIV infection; and S-555739 for suppressing aggravation of COVID-19. In addition, the company develops S-540956 for nucleic acid adjuvant; S-109802 for post-stroke spasticity; S-151128 for chronic pain; S-588210 and S-531011 for solid tumor; S-309309 for obesity; BPN14770 for Alzheimer's disease and fragile X syndrome; S-588410 for bladder cancer; S-488210 for head and neck squamous cell carcinoma; S-005151 for Acute ischemic stroke and epidermolysis bullosa; Rizmoic for opioid-induced constipation; ADR-001 for decompensated liver cirrhosis; S-222611 for malignant tumor; S-812217 for depression; GRT7039 for pain associated with osteoarthritis of the knee; SDT-001 for inattentive ADHD; S-588410 for esophageal cancer; SR-0379 for cutaneous ulcer; and S-723595 for type 2 diabetes. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.", "fullTimeEmployees": 4959, "companyOfficers": [{"maxAge": 1, "name": "Dr. Isao  Teshirogi Ph.D.", "age": 65, "title": "CEO, President & Chairman", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 1836272, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Susumu  Mitsumori", "title": "Vice President of Finance & Accounting Department", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ryuichi  Kiyama Ph.D.", "title": "Senior Executive Officer & Senior VP of Administration Division", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Takeshi  Shiota Ph.D.", "title": "Corporate Officer and Senior VP of Corporate Quality Assurance, Ethics & Compliance Management Div.", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yoshimasa  Kyokawa", "title": "Vice President of Corporate Communications & Secretary Office", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Yoshihiro  Furuya", "title": "Vice President of General Marketing and Compliance Officer of Corporate GXP Compliance Office", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kohji  Hanasaki Ph.D.", "title": "Senior Executive Officer and Senior VP of Supply Supervisory Unit", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. John A.  Keller Ph.D.", "age": 59, "title": "Senior Executive Officer and Senior VP of R&D Supervisory Unit", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kazuhiro  Hatanaka", "title": "Senior Executive Officer & Senior VP of Corporate Strategy Division", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Akira  Kato Ph.D.", "title": "Senior Executive Officer & President of Shionogi Pharma Co., Ltd", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.shionogi.co.jp/ir_en/highlight/index.html", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.7, "open": 7.7, "dayLow": 7.7, "dayHigh": 7.74, "regularMarketPreviousClose": 7.7, "regularMarketOpen": 7.7, "regularMarketDayLow": 7.7, "regularMarketDayHigh": 7.74, "dividendRate": 0.18, "dividendYield": 2.37, "exDividendDate": 1727654400, "payoutRatio": 0.2713, "fiveYearAvgDividendYield": 1.98, "beta": 0.224, "trailingPE": 11.5223875, "forwardPE": 3.125506, "volume": 944, "regularMarketVolume": 944, "averageVolume": 190651, "averageVolume10days": 61990, "averageDailyVolume10Day": 61990, "bid": 7.7, "ask": 7.74, "bidSize": 400, "askSize": 400, "marketCap": 13153336320, "fiftyTwoWeekLow": 6.22, "fiftyTwoWeekHigh": 8.86, "priceToSalesTrailing12Months": 0.02879017, "fiftyDayAverage": 7.21732, "twoHundredDayAverage": 7.1000648, "trailingAnnualDividendRate": 113.333, "trailingAnnualDividendYield": 14.718572, "currency": "USD", "tradeable": false, "enterpriseValue": -258938699776, "profitMargins": 0.36905998, "floatShares": 850115642, "sharesOutstanding": 1701369984, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.00011, "impliedSharesOutstanding": 1703800064, "bookValue": 1581.771, "priceToBook": 0.0048806053, "lastFiscalYearEnd": 1711843200, "nextFiscalYearEnd": 1743379200, "mostRecentQuarter": 1735603200, "earningsQuarterlyGrowth": 0.383, "netIncomeToCommon": 168611004416, "trailingEps": 0.67, "forwardEps": 2.47, "lastSplitFactor": "3:2", "lastSplitDate": 1727827200, "enterpriseToRevenue": -0.567, "enterpriseToEbitda": -1.37, "52WeekChange": -0.12405443, "SandP52WeekChange": 0.12744582, "quoteType": "EQUITY", "currentPrice": 7.72, "targetHighPrice": 9.0, "targetLowPrice": 9.0, "targetMeanPrice": 9.0, "targetMedianPrice": 9.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 305578999808, "totalCashPerShare": 359.215, "ebitda": 189015998464, "totalDebt": 23057000448, "quickRatio": 4.143, "currentRatio": 7.636, "totalRevenue": 456868986880, "debtToEquity": 1.692, "revenuePerShare": 268.2435, "returnOnAssets": 0.073359996, "returnOnEquity": 0.12998, "grossProfits": 395634016256, "freeCashflow": 10346250240, "operatingCashflow": 206821998592, "earningsGrowth": 0.408, "revenueGrowth": 0.126, "grossMargins": 0.86597, "ebitdaMargins": 0.41372, "operatingMargins": 0.44599, "financialCurrency": "JPY", "symbol": "SGIOY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "shortName": "Shionogi & Co. Ltd.", "longName": "Shionogi & Co., Ltd.", "regularMarketTime": 1741376164, "exchange": "PNK", "messageBoardId": "finmb_875364", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.25974002, "regularMarketPrice": 7.72, "marketState": "CLOSED", "epsTrailingTwelveMonths": 0.67, "epsForward": 2.47, "fiftyDayAverageChange": 0.5026798, "fiftyDayAverageChangePercent": 0.0696491, "twoHundredDayAverageChange": 0.61993504, "twoHundredDayAverageChangePercent": 0.087313995, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1448980200000, "regularMarketChange": 0.01999998, "regularMarketDayRange": "7.7 - 7.74", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 190651, "fiftyTwoWeekLowChange": 1.5, "fiftyTwoWeekLowChangePercent": 0.24115756, "fiftyTwoWeekRange": "6.22 - 8.86", "fiftyTwoWeekHighChange": -1.1399999, "fiftyTwoWeekHighChangePercent": -0.12866816, "fiftyTwoWeekChangePercent": -12.405443, "dividendDate": 1576540800, "earningsTimestamp": 1747022400, "earningsTimestampStart": 1747022400, "earningsTimestampEnd": 1747022400, "earningsCallTimestampStart": 1738321140, "earningsCallTimestampEnd": 1738321140, "isEarningsDateEstimate": false, "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]